Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01808196 · ClinicalTrials.gov registry record · Phase 2
Testing Effectiveness of Losartan in Patients With EoE With or Without a CTD
A Phase 2 study of Eosinophilic Esophagitis and Connective Tissue Disorders, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- Phase 2
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT01808196: Completed Phase 2 study of Eosinophilic Esophagitis and Connective Tissue Disorders, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT01808196 is a Phase 2 study of Eosinophilic Esophagitis and Connective Tissue Disorders that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 6 participants, below the 864-participant average among 44 other Eosinophilic Esophagitis trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01808196, a Phase 2 study of Eosinophilic Esophagitis and Connective Tissue Disorders, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to test the safety of losartan potassium and see what effects (good and bad) it has on you and your eosinophilic esophagitis.
Primary Outcome
Percent of participants with peak eosinophil count \< 15 eosinophils/high power field (remission) in distal and proximal esophagus
Conditions Studied
Interventions
- DRUG Losartan Potassium
Study Locations (1)
Ohio
- Kara Kliewer - Mason
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2013-10-10 |
| Est. Completion | 2015-02-13 |
| Phase | Phase 2 |
What the finished NCT01808196 record still lists
NCT01808196 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 864-participant average among 44 other Eosinophilic Esophagitis trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Eosinophilic Esophagitis appearing as the primary indexed condition, and to 1 intervention - of which Losartan Potassium is the first listed.
NCT01808196 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT01808196 about?
NCT01808196 is a clinical study titled "Testing Effectiveness of Losartan in Patients With EoE With or Without a CTD". The purpose of this research study is to test the safety of losartan potassium and see what effects (good and bad) it has on you and your eosinophilic esophagitis.
What is the current status of trial NCT01808196?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 6 participants. The study started on 2013-10-10. Estimated completion is 2015-02-13.
What conditions does trial NCT01808196 study?
This clinical trial studies the following conditions: Eosinophilic Esophagitis, Connective Tissue Disorders.
What interventions are being tested in trial NCT01808196?
The interventions under investigation include: Losartan Potassium (DRUG).
Who is sponsoring clinical trial NCT01808196?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01808196 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Eosinophilic Esophagitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01808196's enrollment target sits among peer trials
6 45th of 44 the lowest of 44 other Eosinophilic Esophagitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Eosinophilic Esophagitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to Evaluate Vonoprazan 20 mg Up to 24 Weeks
RECRUITING · Phase 2
-
Dupilumab Versus Topical Corticosteroid Effectiveness - Comparison in the Treatment of Stenotic EoE
RECRUITING · Phase 2
-
Zemaira Eosinophilic Esophagitis Pilot Study
RECRUITING · Phase 2
-
Efficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects Aged 5 to 18 Years
COMPLETED · Phase 2
-
A Study of Flovent in Patients With Eosinophilic Esophagitis
COMPLETED · Phase 2
-
Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI